People Carl Figdor Tumor micro--environment

Develop novel biomarkers

This research group tries to develop novel prognostic and predictive biomarkers, by studying tumor and blood samples from patients treated with dendritic cell vaccines. An in vitro 3D-Skin model was built to systematically study tumor- microenvironment interactions including immune cell migration.

Research group leader

Carl Figdor PhD
full professor

+31 (0)24 361 76 83
contact

Team

Radboud Institute for Molecular Life Sciences

Our main aim is to achieve a greater understanding of the molecular mechanisms of disease. By integrating fundamental and clinical research, we obtain multifaceted knowledge of (patho)physiological processes. read more